These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2792714)

  • 1. [Biochemical and functional characteristics of erythrocytes in paroxysmal nocturnal hemoglobinuria].
    Andreeva AP; Levina AA; Dmitrieva MG; Kazanets EG; Soboleva SS
    Gematol Transfuziol; 1989 Jul; 34(7):23-6. PubMed ID: 2792714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between the proportion of paroxysmal nocturnal hemoglobinuria (PNH) III-erythrocytes and the frequency of exacerbated hemoglobinuria in PNH.
    Shichishima T; Terasawa T; Uchida T; Maruyama Y
    Eur J Haematol; 1991 Sep; 47(3):235-6. PubMed ID: 1915809
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunophenotyping of Paroxysmal Nocturnal Hemoglobinuria (PNH).
    Illingworth AJ; Marinov I; Sutherland DR
    Methods Mol Biol; 2019; 2032():323-354. PubMed ID: 31522427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal hemoglobin in paroxysmal nocturnal hemoglobinuria (PNH): evidence for derivation of HbF-containing erythrocytes (F cells) from the PNH clone as well as from normal hemopoietic stem cell lines.
    Papayannopoulou T; Rosse W; Stamatoyannopoulos G
    Blood; 1978 Oct; 52(4):740-9. PubMed ID: 356915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in electrophoretic mobility pattern of erythrocytes in patients with paroxysmal nocturnal hemoglobinuria.
    Hayashi H; Fujii M; Yoshikumi C; Kawai Y; Watanabe N; Watanabe K; Fusama M; Shishido H
    J Clin Lab Immunol; 1987 Jun; 23(2):77-81. PubMed ID: 3625755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytometric analysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Bunyaratvej A; Butthep P
    J Med Assoc Thai; 1992 Jan; 75 Suppl 1():237-42. PubMed ID: 1402472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The membrane abnormalities in paroxysmal nocturnal hemoglobinuria (PNH).
    Rosse WF; Adams JP
    Prog Clin Biol Res; 1979; 30():457-61. PubMed ID: 531036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on red blood cell choline transport induced by different sulfhydryl compounds.
    Falezza GC; Olivieri O; Corrocher R; De Sandre G
    Acta Haematol; 1984; 72(2):111-6. PubMed ID: 6437112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of a stabilized whole-blood preparation as a process control material for screening of paroxysmal nocturnal hemoglobinuria by flow cytometry.
    Richards SJ; Whitby L; Cullen MJ; Dickinson AJ; Granger V; Reilly JT; Hillmen P; Barnett D
    Cytometry B Clin Cytom; 2009 Jan; 76(1):47-55. PubMed ID: 18777525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxysmal nocturnal hemoglobinuria. II. Permeability and phosphate turnover in the red blood cells.
    HELLEM AJ; SKAUG OE
    Scand J Clin Lab Invest; 1955; 7(2):121-5. PubMed ID: 13255805
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression of blood group i antigen and fetal hemoglobin in paroxysmal nocturnal hemoglobinuria.
    Navenot JM; Muller JY; Blanchard D
    Transfusion; 1997 Mar; 37(3):291-7. PubMed ID: 9122902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potassium transport in the acetylcholinesterase-deficient erythrocytes of paroxysmal nocturnal hemoglobinuria (PNH).
    AUDITORE JV; HARTMANN RC; COLE EF
    J Clin Invest; 1959 Apr; 38(4):702-6. PubMed ID: 13641422
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
    Amer J; Zelig O; Fibach E
    Exp Hematol; 2008 Apr; 36(4):369-77. PubMed ID: 18261835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An increased calcium accumulation in ATP-depleted red cells of the patients with paroxysmal nocturnal hemoglobinuria.
    Shimoda M; Yawata Y
    Am J Hematol; 1985 Dec; 20(4):325-35. PubMed ID: 4073008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
    Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF
    J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro.
    Moore JG; Frank MM; Müller-Eberhard HJ; Young NS
    J Exp Med; 1985 Oct; 162(4):1182-92. PubMed ID: 2413153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of platelets by flow cytometry in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).
    Araten DJ; Boxer D; Zamechek L; Sherman E; Nardi M
    Blood Cells Mol Dis; 2020 Feb; 80():102372. PubMed ID: 31710879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones.
    Park SH; Jeong J; Lee SH; Yoo DW; Choi Y; Jo JC; Lim JH
    Ann Lab Med; 2019 Mar; 39(2):150-157. PubMed ID: 30430777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The erythrocyte acetylcholinesterase enzyme in paroxysmal nocturnal hemoglobinuria.
    AUDITORE JV; HARTMANN RC; FLEXNER JM; BALCHUM OJ
    Arch Pathol; 1960 May; 69():534-43. PubMed ID: 13795052
    [No Abstract]   [Full Text] [Related]  

  • 20. Paroxysmal nocturnal hemoglobinuria. II. Erythrocyte acetylcholinesterase defect.
    AUDITORE JV; HARTMANN RC
    Am J Med; 1959 Sep; 27():401-10. PubMed ID: 13795054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.